A CYP46 T/C SNP modulates parahippocampal and hippocampal morphology in young subjects by Hänggi, Jürgen et al.
University of Zurich
Zurich Open Repository and Archive
Winterthurerstr. 190
CH-8057 Zurich
http://www.zora.uzh.ch
Year: 2011
A CYP46 T/C SNP modulates parahippocampal and
hippocampal morphology in young subjects
Hänggi, J; Mondadori, C R; Buchmann, A
http://www.ncbi.nlm.nih.gov/pubmed/19647891.
Postprint available at:
http://www.zora.uzh.ch
Posted at the Zurich Open Repository and Archive, University of Zurich.
http://www.zora.uzh.ch
Originally published at:
Hänggi, J; Mondadori, C R; Buchmann, A (2011). A CYP46 T/C SNP modulates parahippocampal and
hippocampal morphology in young subjects. Neurobiology of Aging, 32(6):1023-1032.
http://www.ncbi.nlm.nih.gov/pubmed/19647891.
Postprint available at:
http://www.zora.uzh.ch
Posted at the Zurich Open Repository and Archive, University of Zurich.
http://www.zora.uzh.ch
Originally published at:
Hänggi, J; Mondadori, C R; Buchmann, A (2011). A CYP46 T/C SNP modulates parahippocampal and
hippocampal morphology in young subjects. Neurobiology of Aging, 32(6):1023-1032.
A CYP46 T/C SNP modulates parahippocampal and
hippocampal morphology in young subjects
Abstract
There is evidence that brain cholesterol metabolism modulates the vulnerability for Alzheimer's disease
(AD). Previous data showed that brain beta-amyloid load in elderly subjects with the CYP46
(cholesterol 24S-hydroxylase) TT-positive genotype was higher than in CYP46 TT-negative elderly
subjects. We investigated effects of the CYP46 T/C polymorphism on parahippocampal and
hippocampal grey matter (GM) morphology in 81 young subjects using structural magnetic resonance
imaging based morphometry. We found that young TT-homozygotes exhibited smallest and
CC-homozygotes largest parahippocampal and hippocampal GM volumes with the volumes of the
CT-heterozygotes ranging in between. Parahippocampal and hippocampal volumes were positively
correlated with delayed memory performance in C-carriers and negatively with immediate memory
performance in TT-homozygotes. It has been shown that the brain cholesterol metabolism in general
modulates dendrite outgrowth, synaptogenesis, and neuron survival, and it was suggested that CYP46
indirectly influences beta-amyloid metabolism. CYP46 C-carriers are privileged both in terms of
beta-amyloid metabolism and in terms of brain reserve due to their larger parahippocampal and
hippocampal structures. The exact cellular mechanisms that translate the CYP46 allelic variation into
volumetric brain differences in the parahippocampal gyrus and hippocampus are still unknown and need
to be further investigated.
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Abstract 
There is evidence that brain cholesterol metabolism modulates the vulnerability for 
Alzheimer’s disease (AD). Previous data showed that brain -amyloid load in elderly subjects 
with the CYP46 (cholesterol 24S-hydroxylase) TT-positive genotype was higher than in CYP46 
TT-negative elderly subjects. We investigated effects of the CYP46 T/C polymorphism on 
parahippocampal and hippocampal grey matter (GM) morphology in 81 young subjects using 
structural magnetic resonance imaging based morphometry. We found that young TT-
homozygotes exhibited smallest and CC-homozygotes largest parahippocampal and 
hippocampal GM volumes with the volumes of the CT-heterozygotes ranging in between. 
Parahippocampal and hippocampal volumes were positively correlated with delayed memory 
performance in C-carriers and negatively with immediate memory performance in TT-
homozygotes. It has been shown that the brain cholesterol metabolism in general modulates 
dendrite outgrowth, synaptogenesis, and neuron survival, and it was suggested that CYP46 
indirectly influences -amyloid metabolism. CYP46 C-carriers are privileged both in terms of 
-amyloid metabolism and in terms of brain reserve due to their larger parahippocampal and 
hippocampal structures. The exact cellular mechanisms that translate the CYP46 allelic 
variation into volumetric brain differences in the parahippocampal gyrus and hippocampus are 
still unknown and need to be further investigated. 
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1. Introduction 
The cytochrome 450 pigment 46 enzyme (CYP46, cholesterol 24S-hydroxylase) is a subfamily 
of cytochrome P450 proteins. This protein is anchored in the endoplasmatic reticulum. The 
most important function of cholesterol is to provide eukaryotic plasma membranes both 
stability and flexibility. CYP46 degrades cholesterol mainly to 24S-hydroxycholesterol (24-
OHC). The conversion of cholesterol to 24-OHC is a mechanism for the elimination of excess 
cholesterol from and maintenance of cholesterol homeostasis in the brain (Björkhem et al., 
1997). This mechanism is modulated by age (Lütjohann et al., 1996). There is no cholesterol 
import into the brain; hence, brain cholesterol availability depends entirely on local production. 
Being a constituent of myelin and neural cell membranes, cholesterol is important for brain 
function. Studies also suggest that cholesterol plays an important role in regulating β-amyloid 
(Aβ) metabolism (Papassotiropoulos et al., 2003; Puglielli et al., 2003; Simons et al., 1998; 
Wolozin, 2003). Therefore, a loss of CYP46 activity might produce a corresponding increase in 
Aβ accumulation that may lead to neurodegeneration. 
Although preliminary findings point toward an influence of this cholesterol turnover 
mechanism on the vulnerability for Alzheimer’s disease (AD), it is still disputed whether this 
SNP (rs754203 on intron 2) in the CYP46 gene (on chromosome 14q32.1) is a risk factor for 
AD. CYP46 TT-positive patients with AD were found to have increased cholesterol levels in 
cerebrospinal fluid (CSF) compared with CYP46 TT-negative patients with AD 
(Papassotiropoulos et al., 2003), albeit only on a trend level toward significance (p = 0.07). 
These increased cholesterol levels presumably coincide with a loss of CYP46 activity 
(Papassotiropoulos et al., 2003). The majority of studies found the TT-genotype to be the risk 
variant for AD, while this was the case for the CC-genotype only in a few studies (Helisalmi et 
al., 2006). Most of the studies on this CYP46 SNP and its association with AD were meta-
analysed by Helisalmi et al. (2006). An interaction of the CYP46 T/C SNP with the ε4 allele of 
the apolipoprotein E (ApoE) gene synergistically increases the risk for AD (Papassotiropoulos 
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et al., 2003). Recently, Reiman and colleagues used 18fluoro-2-deoxyglucose (FDG) positron 
emission tomography (PET) to measure regional cerebral blood flow (rCBF) and showed that 
cholesterol-related genes modulate brain metabolism. These authors revealed hypometabolism 
in AD-affected brain regions in healthy elderly subjects who are carriers of the negative allelic 
variant of several cholesterol-related genes including the CYP46 TT-genotype, even when 
controlling for the effects of ApoE 4 gene dose (Reiman et al., 2008). 
Also, there is accumulating and converging evidence that the brain cholesterol metabolism 
plays an important role in dendrite outgrowth, synaptogenesis, and neuronal survival. First, it 
has been shown that cholesterol complexed to ApoE-containing lipoproteins controls 
synaptogenesis in the central nervous system (Mauch et al., 2001). Second, it has been reported 
that cholesterol deficiency causes a selective inhibition of dendrite outgrowth due to the 
decreased stability of microtubules as a result of inhibition of microtubule-associated protein 2 
(MAP2) phosphorylation (Fan et al., 2002). Third, inhibition of cholesterol production in the 
brain tissue cultures induced neuronal cell death (Michikawa and Yanagisawa, 1999). Fourth, it 
has been suggested that the deleterious effects of ethanol on the developing brain might be due, 
at least in part, to an effect on cholesterol homeostasis (Guzzetti and Costa, 2007). Last, there 
are inborn defects in cholesterol metabolism such as the Smith-Lemli-Opitz syndrome (Tint et 
al., 1994), a failure in cholesterol production accompanied by microcephaly, and the Niemann-
Pick type C disease, a failure in cholesterol degradation accompanied by neurodegeneration 
(Sévin et al., 2007). Taken together, there is good evidence that brain cholesterol and its 
metabolism are important for the formation and maintenance of neural tissue as well as for 
neural functions. Because neuropathologic changes in Alzheimer’s disease precede the 
occurrence of the first cognitive symptoms by decades (Mondadori et al., 2006), we anticipated 
that there might be structural brain differences in the medial temporal lobe already in young 
healthy subjects with the CYP46 TT-genotype. 
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Hence, we hypothesized that the CYP46 T/C SNP affects neural tissue, preferentially in brain 
structures with a high metabolic turnover such as the hippocampus and in fact the whole 
medial temporal lobe (MTL), which is first affected by Alzheimer’s pathology. Here, we report 
first findings of the influence of the CYP46 T/C SNP (rs754203) on parahippocampal and 
hippocampal morphology in healthy young Swiss subjects of Caucasian origin, while 
simultaneously controlling for the allelic variation in other genes with known influences on 
brain morphology and memory functions such as the gene that encodes for the brain-derived 
neurotrophic factor and the apolipoprotein gene that is associated with AD. 
 
 
2. Methods 
2.1. Subjects 
The 81 participants were drawn from a larger sample of 354 healthy, young Swiss subjects of 
Caucasian origin (de Quervain et al., 2003). The 354 volunteers were university students and 
employees/trainees recruited at the university of Zurich and via advertisements in local 
newspapers. The 81 subjects already participated in two functional magnetic resonance 
imaging studies that investigated brain activity elicited by memory tasks between different 
apolipoprotein E genotypes (Mondadori et al., 2007) and between different prion protein 
genotypes (Buchmann et al., 2008). Our sample is homogenous with respect to age, education, 
and memory performance. The subjects reported no past or current psychiatric or neurological 
problems and denied taking illegal drugs or medication. All subjects gave written informed 
consent to participate in the study after the nature and possible consequences of the study had 
been explained. The local ethics committee approved the experiment. The subjects were paid 
for participating in the study. 
2.2. Genotyping 
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Information on polymorphic sites was derived from the database of single nucleotide 
polymorphisms (dbSNP) (http://www.ncbi.nlm.nih.gov/SNP/index.html). Genotyping is 
described in detail elsewhere: for the cholesterol 24S-hydroxylase (CYP46; rs754203) gene 
(Papassotiropoulos et al., 2003), for the brain-derived neurotrophic factor (BDNF; rs6265) 
gene (Egan et al., 2003), for the apolipoprotein E (ApoE) gene (Nauck et al., 2000), for the 
serotonin 2a receptor (5-HT2a; rs6314) gene (de Quervain et al., 2003), and for the prion 
protein (PrnP; rs1799990) gene (Papassotiropoulos et al., 2005a). We also controlled for 
nonrandom genetic heterogeneity (hidden population structures) by genotyping each subject 
for 27 unlinked SNPs located in non-genic regions distributed over all autosomes 
(Papassotiropoulos et al., 2005b). 
2.3. Neuropsychology 
Memory performance (immediately after stimulus presentation as well as at delays of 5 min. 
and 24 h.) was assessed during two consecutive days using the Rey-15-figures free recall test 
(Rey, 1958), the recurring figures recognition test (Kimura, 1963), and an in-house developed 
verbal free recall test of 30 common German words, a test already applied and described in 
other publications (Papassotiropoulos et al., 2005a; de Quervain et al., 2003). The difficult in-
house verbal free recall test had been developed to avoid ceiling effects that commonly occur 
when investigating cognitively high functioning subjects such as university students with other 
verbal memory tests. On the first day, subjects viewed six sets of semantically unrelated nouns 
(five nouns per set) presented at a rate of 1 word per second with the instruction to learn the 
words for immediate free recall after each series. In addition, subjects underwent an 
unexpected delayed free recall test of the learned words after 5 minutes and again after 24 
hours. Both delayed free recall tests reflect episodic memory (Squire and Alvarez, 1995). 
In addition to the verbal memory test, subjects performed a modified version of the Rey-15-
figures free recall test (Rey, 1958), which included the presentation of 15 figures in sequence – 
each figure for 2 seconds – with the instruction to learn them for immediate recall. In addition, 
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subjects underwent an unexpected delayed free recall test of the learned figures after 5 minutes 
and again after 24 hours. 
In addition to the two free recall memory tests, we also applied a non-verbal recognition 
memory test using 13 complex figures of the recurring figures recognition test (Kimura, 1963). 
This test requires the presentation of geometric or irregular nonsense figures – each figure for 2 
seconds – that have to be learned for later recognition at delays of 5 minutes and 24 hours. 
All reported memory scores are hits minus false alarms. Maximal scores are: 15 for the Rey-
Figures Test; 13 for the Recurring Figures Test; and 30 for the list of common words. 
Additionally, we applied three different subscales of the revised Wechsler adult intelligence 
scale (WAIS-R) (Wechsler, 1981; German version: Tewes, 1991) to assess working memory 
capacity (Digit span, forward and backward), visuospatial cognition (Block design), and verbal 
reasoning (Similarities). A summary of the neuropsychological test results between the three 
different CYP46 genotypes can be found in Table 1. 
2.4. Magnetic resonance imaging data acquisition 
Magnetic resonance imaging (MRI) scans were acquired on a 3T Philips Intera whole body 
scanner (Philips, Best, the Netherlands) equipped with a commercial eight-element head coil 
array. A T1-weighted gradient echo (fast field echo) sequence was applied with a measured 
spatial resolution of 1.0x1.0x1.0 mm (acquisition matrix 224x224 pixels) and a reconstructed 
resolution of 0.9x0.9x0.8 mm, echo-time TE=2.3 ms, repetition-time TR=20 ms, flip angle FA 
θ=20°. 
2.5. Preprocessing of magnetic resonance imaging data 
Image preprocessing was done with Statistical Parametric Mapping (SPM5) software 
(http://www.fil.ion.ucl.ac.uk/spm) using voxel-based morphometry (VBM) (Ashburner and 
Friston, 2000) implemented in the VBM5 toolbox (http://dbm.neuro.uni-jena.de/vbm/). A 
Hidden Markov Random Field (HMRF) model was applied to enhance the accuracy of the 
tissue class segmentation process (http://dbm.neuro.uni-jena.de/vbm/markov-random-fields/). 
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Customized a priori maps from the normalized, segmented, HMRF weighted, unsmoothed GM, 
white matter (WM), and CSF images of the subjects were constructed. Native images were 
again segmented with the customized a priori maps resulting in normalized, segmented, 
Jacobian modulated, and HMRF weighted GM images which were smoothed with a 9 mm 
Gaussian kernel. Images were subjected into a voxel-wise analysis on one hand and the 
unsmoothed versions were used for the volumes-of-interest (VOIs) approach on the other hand. 
VOIs for the parahippocampal gyri and for the hippocampi were derived from the Pickatlas 
(http://www.fmri.wfubmc.edu/cms/software#PickAtlas). These VOIs were originally drawn by 
others (Tzourio-Mazoyer et al., 2002) on the MNI single-subject brain (Holmes et al., 1998). 
We also normalized and segmented the MNI single-subject brain to obtain the warping 
parameters to adjust this brain onto the customized a priori maps. We then applied these 
transformations to the VOIs to adjust them onto the customized a priori maps, multiplied the 
VOIs by the GM images, and computed the volumes within these VOIs. Note that both the 
voxel-based and the VOI-based approach are fully automated procedures and therefore they are 
operator-independent. 
2.6. Statistical analyses 
We used SPM5 and SPSS 14 (http://www.spss.com/) to analyze voxel- and VOI-based data, 
respectively. Partial correlations between CYP46 allelic frequency and parahippocampal or 
hippocampal volumes controlling for total GM volume (TGMV) and BDNF genotype as well 
as analysis of covariance (ANCOVA) models were applied. In the ANCOVAs, the allelic 
variant was the independent variable and parahippocampal and hippocampal volumes the 
dependent variables while TGMV and BDNF genotype were used as covariates. Gender and 
TGMV are collinear variables (Spearman correlation: r = - 0.657, p = 2.82*10-11, male coded 
as 1, female coded as 2), i.e., TGMV explains most of the gender-related variance in brain 
morphology; hence, gender was not included in our statistical models to preserve statistical 
power. Education, handedness, and age showed no significant influence on morphology (tested 
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in multiple regression analyses together with TGMV and BDNF genotype) and were therefore 
not modeled in both analyses. We controlled for SNPs with published influences on brain 
morphology such as found in the BDNF gene (Egan et al., 2003; Hariri et al., 2003; Pezawas et 
al., 2004; Szeszko et al., 2005; Bueller et al., 2006) and 5-HT2a gene (Filippini et al., 2006), 
and for SNPs with potential influences on morphology such as found in the ApoE gene 
(Mondadori et al., 2007) and PrnP gene (Papassotiropoulos et al., 2005a), as well as for 
nonrandom genetic heterogeneity, i.e., hidden, genetic population structure (Papassotiropoulos 
et al., 2005b). Allelic frequencies of the SNPs with potential influences and the 5-HT2a SNP 
were not significantly different between the CYP46 genotypes and were not considered further. 
Although the allelic frequency of the BDNF SNP was not statistically different between the 
three CYP46 genotypes it was included in our statistical models as a covariate because of its 
relevance on medial temporal lobe morphometry as well as memory functions (Egan et al., 
2003; Hariri et al., 2003; Pezawas et al., 2004; Szeszko et al., 2005; Bueller et al., 2006). VBM 
results were thresholded with an error probability of p < 0.001 (uncorrected for multiple 
comparisons) combined with a cluster extent threshold of k = 50 voxels (uncorrected). In order 
to account for the multiple comparisons problem we applied a small volume correction (SVC) 
that restricts the statistical analysis to the medial temporal lobe. This SVC was combined with 
a false discovery rate (FDR) of p = 0.05. For the VOI-based data, we used a common threshold 
of p < 0.05 (uncorrected). We correlated the parahippocampal and hippocampal volumes with 
memory performance and with the CYP46 T-allele frequency and the latter also with memory 
performance. We applied two different types of correlations, a partial product-moment 
correlation according to Pearson that controls for TGMV and BDNF genotype, and a rank 
correlation according to Spearman. The rank correlations were based on residual values after 
the effects of TGMV and BDNF genotype on hippocampal and parahippocampal volumes were 
regressed out. 
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3. Results 
Demographic characteristics, memory performance, indices of intelligence, and global brain 
tissue volumes are shown in Table 1. There were neither significant differences nor trends 
toward significance (0.05 < p < 0.1) between the CYP46 genotypes for the variables age, years 
of education, TGMV, total WM volume, total CSF volume, intracranial volume, indices of 
intelligence, and for any of the free recall and recognition memory measure as revealed by 
AN(C)OVAs. Nor were there significant differences in the distribution of BDNF, 5-HT2a, 
ApoE, PrnP, GenHet allele frequencies, gender, and handedness between CYP46 genotypes as 
assessed with χ2-tests. As expected, CYP46 genotype distribution was under Hardy-Weinberg 
equilibrium conditions. 
We found volumetric GM differences in the medial temporal lobe (MTL) structures between 
the CYP46 genotypes (Figs. 1 and 3) as a result of both the correlations (Fig. 1 left) and 
ANCOVAs (Fig. 1 right). Voxel-wise (Figs. 1 and 2) and VOI-based (Fig. 3; Table 2) analyses 
revealed that both parahippocampal gyri and both hippocampi were smaller in TT-
homozygotes than in CT-heterozygotes and in turn than in CC-homozygotes. In the voxel-wise 
analyses (Fig. 1), the left parahippocampal cluster size is 7984 voxels (p < 0.001 uncorrected; p 
= 0.003 FDR corrected) as revealed by correlation and 2322 voxels (p < 0.001 uncorrected; p = 
0.024 FDR corrected) as revealed by ANCOVA. The right parahippocampal cluster size is 785 
voxels (p < 0.001 uncorrected; p = 0.004 FDR corrected) as yielded by the correlation analysis. 
In the VOI-based analyses (Fig. 3), the differences of the parahippocampal and hippocampal 
volumes between TT- and CC-homozygotes were all significant, whereas the volumetric 
differences between the homozygotes and the CT-heterozygotes showed only a trend toward 
significance (see Fig. 3). As stated above in the Methods, we did not model gender in our 
analyses because gender is collinear to TGMV. Nevertheless, we also analyzed our data with 
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TGMV and gender as simultaneous covariates. Theses analyses revealed qualitatively and 
quantitatively similar results. 
Furthermore, we obtained negative findings with respect to an influence of the BDNF and the 
5-HT2a SNP on hippocampal volumes. This is in contrast with the literature where the BDNF 
val66met-allele (Egan et al., 2003; Hariri et al., 2003; Pezawas et al., 2004; Szeszko et al., 
2005; Bueller et al., 2006) and the 5-HT2a his452tyr-allele (Filippini et al., 2006) were 
associated with smaller hippocampal volumes. Nevertheless, there was a statistical trend in our 
sample pointing towards an association between BDNF val66met-allele and smaller 
hippocampal and parahippocampal volumes. When CYP46 genotypes were added as a second 
factor to a BDNF-MANCOVA with both hippocampi and parahippocampal gyri as dependent 
variables, CYP46 genotypes explained most of the variance in these volumes (BDNF: F = 1.17, 
p = 0.327; CYP46: F = 1.75, p = 0.045). When the hippocampal and parahippocampal volumes 
were analyzed separately, all medial temporal lobe volumes were comparable between the 
different BDNF and 5-HT2a genotypes: left hippocampus (BDNF, p = 0.216; 5-HT2a, p = 
0.459), right hippocampus (BDNF, p = 0.133; 5-HT2a, p = 0.639), left parahippocampal gyrus 
(BDNF, p = 0.114; 5-HT2a, p = 0.279), and right parahippocampal gyrus (BDNF, p = 0.063; 5-
HT2a, p = 0.765). 
Memory performance in the CYP46 genotypes is listed in Table 1. We correlated memory 
performance with the parahippocampal and hippocampal GM volumes derived from the VOIs 
(Table 3). When considering only the significant correlations, a dissociation was found in the 
direction of these correlations: while TT-carriers showed only negative correlations between 
immediate memory performance and parahippocampal and hippocampal volumes, CT- and 
CC-carriers showed only positive correlations between short- and long-delay memory 
performance and parahippocampal and hippocampal volumes. However, when looking also at 
the insignificant correlations there is no further support for such a kind of dissociation. The 
whole pattern of correlations between the different memory measures and parahippocampal 
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and hippocampal volumes across the different CYP46 genotypes can be found in the 
Supplementary Table S1 online. There were no significant correlations between the measures 
of memory performance and the frequency of CYP46 T-alleles. 
 
 
4. Discussion 
We found that the CYP46 T/C SNP (rs754203), a possible risk factor for AD, modulates 
parahippocampal and hippocampal volumes in young, healthy Swiss subjects of Caucasian 
origin. These structures were smaller in TT-homozygotes than in CT-heterozygotes and in turn 
than in CC-homozygotes. The MRI T1-weighted intensity profiles, on which morphometric 
MRI studies are based, have been shown to be best explained by a weighted sum of 
cytoarchitectonic and myeloarchitectonic profiles (Eickhoff et al., 2005), suggesting that the 
volumetric differences originate in differences in neuronal and synaptic compartments, which 
are very important for brain functions, rather than differences in the stroma (including 
interstitial fluid) or edema. 
The significant correlations of parahippocampal and hippocampal GM volumes with various 
measure of memory showed a dissociation between TT-carriers and CT-/CC-carriers. 
Correlations between parahippocampal or hippocampal volumes and immediate recall of 30 
words were negative for TT-homozygotes. Although traditional views do not account for a role 
of MTL structures in short-term memory, there is mounting evidence that the MTL supports 
short-term memory as well, particularly with high mnemonic load and with associative 
learning tasks (Ranganath and Blumenfeld, 2005). The negative correlation between 
parahippocampal or hippocampal volumes and immediate recall of 30 words in TT-carriers is 
difficult to explain given current knowledge. CT-heterozygotes and CC-homozygotes exhibited 
positive correlations between parahippocampal or hippocampal volumes and performance in 
tests of delayed recognition. Associations of larger volumes with better memory performance 
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indicates that neurons in the measured volumes were functionally relevant and therefore carry 
the potential to keep memory functions up at an advanced age when pathological deposits start 
to disturb neural function locally. This relationship in the carriers of the favorable C-allele are 
interpretable in the light of the theory of brain reserve capacity (Katzman et al., 1988; Mori et 
al., 1997) as a protective factor against memory decline due to neurodegeneration at an 
advanced age. This “volume advantage” affords the individual greater physical resistance 
against neural degeneration. Thus, CYP46 T-alleles might mediate a risk for AD (Helisalmi et 
al., 2006; Papassotiropoulos et al., 2003). The suggestion of a protective role of the CYP46 C-
alleles (SNP rs754203) is supported by recent findings in a Chinese population. Fu and 
colleagues showed that elderly subjects with the T allele are more likely to deteriorate in 
cognitive functioning over a two years period compared with those without the T allele (Fu et 
al., 2009). 
Although several morphometric imaging studies found support for an association of the BDNF 
val66met SNP (rs6265) with volumetric differences in MTL structures and memory 
performance (Egan et al., 2003; Hariri et al., 2003; Pezawas et al., 2004; Szeszko et al., 2005; 
Bueller et al., 2006), we were unable to replicate the finding of smaller hippocampal volumes 
in BDNF val66met carriers compared with val66val carriers within our dataset. Possible 
explanations include the diversity of methodological approaches applied to measure the 
volume of interest, the restricted age range of our subjects, the high level of education of our 
academic sample, the fact that we controlled for genetic variation in additional SNPs as well as 
background genetic heterogeneity, and/or the different numbers of BDNF met66met carriers 
between our and the other studies. 
Evidence is accumulating showing that brain cholesterol metabolism plays an important role in 
dendrite outgrowth (Fan et al., 2002), synaptogenesis (Mauch et al., 2001), and neuronal 
survival (Michikawa and Yanagisawa, 1999). Inborn defects in cholesterol metabolism such as 
the Smith-Lemli-Opitz syndrome (Tint et al., 1994) and the Niemann-Pick type C disease 
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(Sévin et al., 2007) disturb brain development profoundly. The exact molecular and cellular 
mechanisms that translate the CYP46 allelic variation into volumetric brain differences in the 
parahippocampal gyrus and hippocampus are still unknown. However, intronic SNPs have 
been shown to modulate genetic risk for AD (Dermaut et al., 2002; Wang et al., 2002) possibly 
through alternative splicing, altered RNA stability, differences in the distribution of the 
enzyme inside the neural cell, or through a linkage disequilibrium with other so far unknown 
loci in the CYP46 gene. Recently, it has been shown that three other SNPs in the CYP46 gene 
(rs7157609, rs4900442, and rs3742376) influence the risk for AD (Kölsch et al., 2009; Fu et 
al., 2009). 
If the found structural differences should turn out to persist in older persons, one might 
speculate that structures may be larger because CYP46 C-alleles favor the non-amyloidogenic 
amyloid precursor protein cleavage pathway by inhibiting the beta-site APP-cleaving enzyme 
(BACE) as suggested by Wolozin (2003), meaning that less Aβ might be produced and 
deposited during lifetime. Less Aβ production and deposition result in less cell destruction and 
preserved neural functionality. Therefore, reduced atrophy and hence better memory functions 
in older age can be expected in CYP46 C-carriers compared with T-carriers. Taken together the 
CYP46 T/C SNP might modulate the vulnerability for AD twofold: through its direct effects on 
the formation of parahippocampal and hippocampal tissue, neuronal survival, and 
synaptogenesis in early life and through its indirect role in regulating β-amyloid metabolism at 
an advanced age. 
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Table 1. Demographic characteristics, memory performance, and brain tissue volumes of 
CYP46 genotypes. Memory measures are hits minus false alarms. * Confirmed by analysis of 
variance and covariance (two-tailed) and by 2 (two-tailed). ** Forward and backward. 
Abbreviations: TGMV, total gray matter (GM) volume; TWMV, total white matter (WM) 
volume; TCSFV, total cerebrospinal fluid (CSF) volume; ICV, intracranial volume; WAIS-R, 
Wechsler adult intelligence scale - revised; f, females; m, males; r, right; l, left, a, ambidexter; 
BDNF, brain-derived neurotrophic factor; 5-HT2a, 5-Hydroxy-tryptamine 2a; ApoE, 
apolipoprotein E; PrnP, prion protein; GenHet, genetic heterogeneity; val, valine; met, 
methionine; his, histidine; tyr, tyrosine; S.D., standard deviation. 
Measures Mean S.D. Min. Max. Mean S.D. Min. Max. Mean S.D. Min. Max. Probability*
Age (years) 22.9 3.5 18.7 39.0 23.2 2.3 19.7 31.0 24.0 3.4 20.0 32.1 0.613
Education (years) 14.5 1.7 10.5 18.0 15.4 1.8 12.0 19.0 15.5 1.1 13.5 17.0 0.104
TGMV (ccm) 781.6 70.4 648.5 947.2 778.8 74.5 657.1 920.6 778.7 79.1 665.2 946.2 0.613
TWMV (ccm) 420.4 46.5 320.9 499.1 428.4 49.6 348.8 584.2 417.2 67.1 353.9 592.2 0.616
TCSFV (ccm) 405.5 63.3 296.1 595.1 412.4 50.6 296.8 516.7 410.3 43.8 350.0 506.5 0.912
ICV (ccm) 1,607.5 143.2 1,313.7 1,909.7 1,619.7 132.8 1,386.4 1,936.3 1,606.1 163.5 1,387.7 1,958.6 0.924
Kimura figures short delay 6.6 3.0 0 12 7.1 3.0 0 13 6.0 2.9 1 9 0.544
Kimura figures long delay 5.3 3.0 -1 11 4.9 2.7 -3 11 5.2 2.7 1 8 0.860
Rey figures short delay 5.6 3.0 1 12 5.2 2.8 -1 12 6.0 4.1 1 12 0.674
Rey figures long delay 3.9 3.4 -7 9 2.4 3.2 -6 -8 3.8 4.6 -2 12 0.178
30 words immediate 22.4 4.0 14 29 22.7 2.9 15 29 22.0 3.7 17 27 0.818
30 words short delay 5.8 3.9 -3 14 6.0 3.5 0 14 5.7 2.4 2 9 0.979
30 words long delay 5.0 3.9 -8 11 3.6 4.2 -6 11 2.3 2.5 -3 5 0.122
Digit span** (WAIS-R) 15.6 3.8 9 25 15.3 3.6 8 21 16.5 3.9 10 23 0.651
Block design (WAIS-R) 42.8 6.9 27 51 43.8 5.4 33 51 43.8 4.5 36 50 0.776
Similarities (WAIS-R) 28.3 2.7 20 32 28.4 2.6 23 32 27.4 4.0 19 32 0.602
Gender (f/m) 0.755
Handedness (r/l/a) 0.624
BDNF val66met 0.526
5-HT2a his452tyr 0.255
PrnP met129val 0.986
ApoE epsilon4 vs not epsilon4 0.195
GenHet 2 clusters 0.6826 cluster 1     4 cluster 2
7 val/val     3 val/met    0 met/met  22 val/val     10 val/met    1 met/met  
5 his/his     5 his/tyr     0 tyr/tyr 
3 epsilon 4     7 not epsilon 4
5 met/met     3 val/met     2 val/val 
15 cluster 1     18 cluster 2
21 val/val     16 val/met     1 met/met 
29 his/his     9 his/tyr     0 tyr/tyr 
6 epsilon 4     32 not epsilon 4
16 met/met     13 val/met     9 val/val 
20 cluster 1     18 cluster 2
24 his/his     9 his/tyr     0 tyr/tyr 
10 epsilon 4     19 not epsilon 4 
13 met/met     12 val/met     7 val/val 
7 / 3
9 / 1 / 0
Frequency of amino acids / alleles Frequency of amino acids / alleles Frequency of amino acids / alleles
21 / 12
28 / 3 / 2
18 / 20
32 / 4 / 2
TT - homozygotes (n = 33) CT - heterozygotes (n = 38) CC - homozygotes (n = 10)
Frequency Frequency Frequency
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Structures - CYP46 genotype
correlation (n = 81) r p d r p d
Left parahippocampal gyrus 0.43 0.00004 0.95 0.39 0.0003 0.85
Right parahippocampal gyrus 0.36 0.001 0.78 0.33 0.002 0.71
Left hippocampus 0.26 0.010 0.52 0.24 0.032 0.49
Right hippocampus 0.23 0.021 0.46 0.20 0.068 0.42
Partial correlation* Spearman correlation*
 
 
Table 2. Correlations between T-allele frequency and parahippocampal or hippocampal 
volumes. Less T-alleles (more C-alleles) mean larger volumes. * Partial correlations corrected 
for total grey matter volume and brain-derived neurotrophic factor (BDNF) allele frequency. 
Probabilities p < 0.05 are in bold, statistical trends towards significance (0.05 < p < 0.1) are in 
italic. Abbreviations: CYP46, cholesterol 24S-hydroxylase; d, Cohen’s effect size; p, error 
probability; r, correlation coefficient. 
 
 
 
Table 3. Correlations between memory performance and parahippocampal or 
hippocampal volumes in the CYP46 genotype groups. * All memory measures are hits minus 
false alarms. ** Correlations are corrected for total grey matter volume and brain-derived 
neurotrophic factor (BDNF) allelic variant. Probabilities p < 0.05 are in bold, statistical trends 
towards significance (0.05 < p < 0.1) are in italic. The whole pattern of correlations can be 
found in the Supplementary Table S1 online. Abbreviations: d, Cohen’s effect size; g., gyrus; 
min., minutes; h., hours; p, error probability; r, correlation coefficient. 
Structures - memory tests*
r p d r p d
TT-homozygotes (n = 33)
Left hippocampus - 30 words immediate recall -0.58 0.001 1.44 -0.51 0.003 1.17
Right hippocampus - 30 words immediate recall -0.45 0.011 1.01 -0.40 0.020 0.88
Left parahippocampal g. - 30 words immediate recall -0.34 0.061 0.72 -0.24 0.185 0.49
Right parahippocampal g. - 30 words immediate recall -0.45 0.011 1.01 -0.45 0.009 1.00
CT-heterozygotes (n = 38)
Right hippocampus - 30 words short delay (5 min.) 0.30 0.080 0.62 0.32 0.048 0.68
Right parahippocampal g. - 30 words short delay (5 min.) 0.34 0.045 0.71 0.28 0.092 0.58
Right hippocampus - 30 words long delay (5 min.) 0.28 0.104 0.57 0.27 0.106 0.55
Right parahippocampal g. - 30 words long delay (24 h.) 0.47 0.004 1.08 0.45 0.005 1.00
CC-homozygotes (n = 10)
Left hippocampus - Rey figures long delay (24 h.) 0.52 0.187 1.22 0.47 0.171 1.06
Right hippocampus - Kimura figures short delay (5 min.) 0.30 0.474 0.62 0.23 0.527 0.47
Left parahippocampal g. - Rey figures long delay (24 h.) 0.28 0.509 0.57 0.18 0.625 0.36
Right parahippocampal g. - 30 words long delay (24 h.) 0.53 0.177 1.25 0.53 0.116 1.25
Spearman correlation**Partial correlation**
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Figure legends 
 
 
Figure 1. Main effect of CYP46 T-alleles on parahippocampal and hippocampal volumes 
revealed by voxel-wise analyses using partial correlation (left) and analysis of covariance 
(right). Total grey matter volume and BDNF allele frequency were used as covariates. Less T-
alleles mean larger volumes. Clusters of volumetric differences are overlaid on the Montreal 
Neurological Institute (MNI) single subject brain. Abbreviations: L, left; R, right; y, y-
coordinate in MNI space. 
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Figure 2. Correlations between CYP46 genotypes and parahippocampal volumes. 
Influences of total grey matter volume and BDNF allele frequency were regressed out. Less T-
alleles go with larger volumes. Plots are shown for two local maxima located in the left and 
right entorhinal cortex. Coordinates are in Montreal Neurological Institute (MNI) space. The y-
axis represents the beta-values of the general linear model. 
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Figure 3. Parahippocampal and hippocampal volumes of the different CYP46 genotype 
groups. Error probabilities are corrected for total grey matter volume and BDNF genotype. 
Shown are mean volumes and the error bar represents the standard deviation. Statistical trends 
(0.05 < p < 0.1) are printed in italic. 
 
